Alvotech Warrant
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic art… Read more
Alvotech Warrant (ALVOW) - Total Assets
Latest total assets as of September 2025: $1.41 Billion USD
Based on the latest financial reports, Alvotech Warrant (ALVOW) holds total assets worth $1.41 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Alvotech Warrant - Total Assets Trend (2020–2024)
This chart illustrates how Alvotech Warrant’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Alvotech Warrant - Asset Composition Analysis
Current Asset Composition (December 2024)
Alvotech Warrant's total assets of $1.41 Billion consist of 37.3% current assets and 62.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.2% |
| Accounts Receivable | $251.72 Million | 20.6% |
| Inventory | $127.89 Million | 10.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $20.62 Million | 1.7% |
| Goodwill | $11.33 Million | 0.9% |
Asset Composition Trend (2020–2024)
This chart illustrates how Alvotech Warrant's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Alvotech Warrant's current assets represent 37.3% of total assets in 2024, an increase from 18.2% in 2020.
- Cash Position: Cash and equivalents constituted 4.2% of total assets in 2024, down from 6.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 3.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 20.6% of total assets.
Alvotech Warrant Competitors by Total Assets
Key competitors of Alvotech Warrant based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Alvotech Warrant - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Alvotech Warrant generates 0.40x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Alvotech Warrant is currently not profitable relative to its asset base.
Alvotech Warrant - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.42 | 2.69 | 1.69 |
| Quick Ratio | 0.74 | 1.92 | 1.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $127.94 Million | $ 272.06 Million | $ 35.18 Million |
Alvotech Warrant - Advanced Valuation Insights
This section examines the relationship between Alvotech Warrant's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 28.6% |
| Total Assets | $1.22 Billion |
| Market Capitalization | $35.01 Million USD |
Valuation Analysis
Below Book Valuation: The market values Alvotech Warrant's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Alvotech Warrant's assets grew by 28.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Alvotech Warrant (2020–2024)
The table below shows the annual total assets of Alvotech Warrant from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $1.22 Billion | +28.56% |
| 2023-12-31 | $950.09 Million | +14.68% |
| 2022-12-31 | $828.44 Million | +38.54% |
| 2021-12-31 | $597.98 Million | +26.04% |
| 2020-12-31 | $474.42 Million | -- |